BioSpace News Archive

Cortexyme, Inc. (Nasdaq: CRTX), a clinical stage biopharmaceutical company pioneering a novel, disease-modifying therapeutic approach to treat what it believes to be a key underlying cause of Alzheimer’s and other degenerative diseases, today announced that its lead investigational medicine, COR388, will be the subject of an oral presentation at Clinical Trials on Alzheimer’s Disease (CTAD) 2019.

Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that in connection with Yash Singh being named Executive Vice President, Cellular & Molecular Technologies on October 31, 2019,

Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic disorders of obesity, today reported financial results and provided a business update for the third quarter ended September 30, 2019.

Genisphere reported a publication in the journal Brain that demonstrates a novel 3DNA® nanocarrier shown to carry a peptide drug through the body and precisely target microglia cells in the brain

Capricor Therapeutics (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment of Duchenne muscular dystrophy and other rare disorders, will report its third quarter of 2019 financial results and corporate update shortly after the NASDAQ market close on Thursday, November 7.

Nationwide sale of rhinestone phone ring and stand raising funds and awareness of living kidney donation ahead of holiday season

Survey reveals scale of epilepsy’s impact on the lives of patients and caregivers - including fear of having a seizure or losing independence

Nektar Therapeutics (NASDAQ:NKTR) announced today that it will webcast an analyst and investor conference call with a melanoma specialist and company management on Sunday, November 10, 2019 at 9:00 a.m. EST in Washington, D.C. during the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting.

Connexient, the healthcare leader in digital wayfinding and indoor navigation, just completed its strongest quarter ever with impressive wins at some of the leading health systems in the country.

Encore Medical Education (www.encoremeded.com) will publish the Official SABCS® News highlighting the key findings presented at the 42nd San Antonio Breast Cancer Symposium (SABCS®), held on December 10-14, 2019 in San Antonio, Texas, USA